E A N A L Y T I C S
FDA 21 CFR Part 11 Compliance for EDC Systems

FDA 21 CFR Part 11 remains the cornerstone regulation for electronic records and signatures in clinical trials. For sponsors and CROs implementing Electronic Data Capture (EDC) systems like eAnalytics EDC Pro, understanding and demonstrating compliance is essential for regulatory acceptance. This comprehensive guide covers the key requirements, validation strategies, and audit preparation techniques to ensure your EDC system meets FDA expectations.

"The regulation requires that electronic records and signatures be trustworthy, reliable, and generally equivalent to paper records. eAnalytics EDC Pro was designed from the ground up with Part 11 compliance as a core architecture principle, not an afterthought."

- Dr. Sarah Chen, Regulatory Affairs Director

Key Part 11 requirements for EDC systems include: (1) validation of system accuracy and reliability, (2) the ability to generate accurate and complete copies of records, (3) protection of records throughout the retention period, (4) computer-generated audit trails, (5) operational system checks, (6) authority checks, (7) device checks, and (8) training documentation. eAnalytics EDC Pro addresses each of these requirements through built-in compliance features, automated validation tools, and comprehensive audit capabilities.

The audit trail functionality in eAnalytics EDC Pro captures all data changes with timestamp, user identification, reason for change, and both old and new values. This secure, computer-generated audit trail cannot be modified or deleted by users, ensuring data integrity throughout the study lifecycle. Our system also provides role-based access controls, electronic signature integration, and automated validation reporting to streamline regulatory submissions and inspections.

Social Share:

(03) Comments:

  1. Dr. Michael Rodriguez
    Dr. Michael Rodriguez

    Excellent overview of Part 11 requirements. We recently validated eAnalytics EDC Pro for a Phase III oncology trial and the audit trail functionality significantly simplified our FDA inspection preparation.

    1. Dr. Sarah Chen
      Dr. Sarah Chen

      Thank you, Dr. Rodriguez! We're glad to hear eAnalytics EDC Pro worked well for your oncology trial. Our team is continuously enhancing the validation documentation package based on client feedback.

  2. Emily Thompson
    Emily Thompson

    Does eAnalytics EDC Pro support hybrid environments where we need to integrate with legacy systems? We're gradually transitioning to electronic records and need Part 11 compliant interfaces.

Leave a Comment: